New IPF drug passes first safety check in small trial
Disease control
Completed
This study tested an experimental drug called PMG1015 in 29 people with idiopathic pulmonary fibrosis (IPF), a serious lung disease that causes scarring and makes breathing hard. The main goal was to see if the drug is safe and how the body handles it. Participants received eithe…
Phase: PHASE1 • Sponsor: Pulmongene Ltd. • Aim: Disease control
Last updated May 17, 2026 07:37 UTC